Primary empty sella syndrome. Observations on 71 cases;Sindrome della sella turcica vuota primitiva. Osservazioni su 71 casi

Recenti Progressi in Medicina

Volumn 90, Issue 2, 1999, Pages 73-80

  Bianconcini, Giuliano ^a,b   Bragagni, Gianpaolo ^b   Bianconcini, Michele ^b  

^a Divisione di Medicina Interna I   (Italy)

^b NONE

Author keywords

Empty sella syndrome; Hypothalamic obesity; Hypothalamic syndromes; Mental disorders; Sella turcica

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EMPTY SELLA SYNDROME; FEMALE; HUMAN; HYPOTHALAMUS DISEASE; MALE; MENTAL DISEASE; MIDDLE AGED; OBESITY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; EMPTY SELLA SYNDROME; FEMALE; HUMANS; HYPOTHALAMIC DISEASES; MALE; MENTAL DISORDERS; MIDDLE AGED; OBESITY;

EID: 0033072492     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Busch W. Die Morphologie der Sella turcica und ihre Beziehungen zur Hypophyse. Virchows Arch Pathol Anat Physiol 1951; 320: 437-58.
2. Bjerre P, Gyldensted C, Riishede J, Lindholm J. The empty sella and pituitary adenomas. A theory on the causal relationship. Acta Neurol Scand 1982; 66: 82-92.
3. Kelestimur F, Selcuklu A, Ozcan N. Empty sella developing during thyroxine therapy in a patient with primary hypotiroidism and hyperprolactinemia. Postgrad Med J 1992; 68: 589-91.
4. Berke JP, Buxton LF, Kokmen E. The "empty" sella. Neurology 1975; 25: 1137-1143b.
5. Bjerre P. The empty sella. A reappraisal of etiology and pathogenesis. Acta Neurol Scand 1990; 82 (Suppl 130): 1-25.
6. Rovit RL, Fein JM. Pituitary apoplexy: a review and reappraisal. J Neurosurg 1972; 37: 280-8.
7. Portocarrero CJ, Robinson AG, Taylor AL, Klein I. Lymphoid hypophysitis : an unusual cause of hyperprolactinemia and enlarged sella turcica. JAMA 1981; 246: 1811.
8. Ishikawa K, Sohmiya M, Furuya H, Kato Y. A case of Sheehan's syndrome associated with severe anemia and empty sella proved 48 years after postpartum hemorrhage. Endocrine Journal 1995; 42: 803-9.
9. Benedetti A, Carbonin C, Colombo F: Possible aetiopathogenetic correlation between primary empty sella and arachnoid cist. Acta Neurochir (Wien) 1977; 38: 269-78.
10. Baldini M, Mosca L, Princi L. The empty sella syndrome secondary to Rathke's cleft cyst. Acta Neurochir (Wien) 1980; 43: 69-78.
11. Neelon FA, Goree GA, Lebovitz HE. The primary empty sella : clinical and radiographic characteristics and endowing function. Medicine (Baltimore) 1973; 52: 73-92.
12. Ducos M, Labarthe F, Latapie JL. Les selles turciques vidées. Bordeaux Med 1977; 10: 363-6.
13. Jordan RM, Kendall JW, Kerber CW. The primary empty sella syndrome. Analysis of the clinical characteristics, radiographic feature, pituitary function and cerebrospinal fluid adenohypophyseal hormone concentrations. Am J Med 1977; 62: 569-80.
14. Schaison G, Metzger J. The primary empty sella. An endocrine study on 12 cases. Acta Endocrinol 1976; 83: 483-92.
15. Bianconcini G, Gobbi F. Empty sella syndrome (ESS) primitiva. Osservazioni cliniche su 20 casi. Minerva Med 1990; 81: 355-62.
16. Brismar K, Efendic S. Pituitary function in the empty sella syndrome. Neuroendocrinology 1981; 32: 583-6.
17. Ekblom M, Ketonen L, Kuuliala I, Pelkonen R. Pituitary function in patients with enlarged sella turcica and primary empty sella syndrome. Acta Med Scand 1981; 209: 31-35.
18. Gallardo E, Schachter D, Caceres E, et al. The empty sella: results of treatment in 76 successive cases and high frequency of endocrine and neurological disturbances . Clin Endocrinol 1992; 37: 529-33.
19. Faglia G, Ambrosi R, Beck-Peccoz P, Giovannelli M.Disorders of growth hormone and corticotropin regulation in patients with empty sella. J Neurosurg 1973; 38: 59-64.
20. Buonaguidi R, Faggionato F, Puglioli M, Lutzenberger L, Ferdeghini M. Sindrome della sella vuota primitiva. Studio clinico, radiologico e valutazione della funzione ipofisaria. Minerva Med 1984; 75: 1589-99.
21. Guillaume J, Garriguez P, Lazorthes Y, Roulleau J, Manelfe C. Selle turcique "vide primitive". A propos de 8 observations et revue de la littérature. J Radiol Electrol 1977; 58: 5-12.
22. Ketonen L, Kuuliala I. Diagnosis of primary Empty Sella Syndrome by Computed Tomography. Ann Clin Res 1979; 11: 125-8.
23. Dedov II, Zenkova TS, Mel'Nichenko GA, Belichenko OI, Fedina ID. The potentials of magnetic resonance tomography in the diagnosis of the "empty" sella turcica. Neurosci & Behavior Physiol 1994; 24: 229-33.
24. Albinet P, Ligeon-Ligeonnet P, Oudart F, Romanet JP, Mouillon M. Syndrome de la selle turcique vide primaire. Bull Soc Ophtalmol Fr 1990; 90: 445-8.
25. Neetens A, Smet H. The empty sella. Bull Soc Belge Ophtalmol 1985; 214: 149-62.
26. Foley KM, Posner JB. Does pseudotumor cerebri cause the empty sella syndrome? Neurology 1975; 25: 565-9.
27. Olson DR, Guiot G, Derome P. The symptomatic empty sella. Prevention and correction via the transsphenoidal approach. J Neurosurg 1972; 37: 533-7.
28. Polyzoidis KS, Fylaktakis M. Trans-sphenoidal extradural chiasmapexy in the management of the symptomatic primary empty sella syndrome. Zentralblatt fur Neurochirurgie 1993; 54: 128-32.
29. Baranowska B, Singh SP, Nowakowski J, Jeske W. The role of opiate, dopaminergic and adrenergic systems in the hypotalamo-pituitary dysfunction in obesity. Acta Endocrinol 1987; 116: 221-8.
30. Grossman A. Oppiacei cerebrali e funzione endocrina. In: Endocrinologia clinica e Metabolismo.Neuroendocrinologia. Roma: Il Pensiero Scientifico Editore, 1984; 298-322.
31. Joseph MG, Jouanny AC, Chomienne F, Champion G, Ginies JL, Limal JM. Syndromes hypothalamiques. Revue de la séméiologie clinique et endocrinienne. Annales de Pediatric 1993; 40: 475-9.
32. Halaas JL, Gaijwala KS, Maffei M, et al. Weight reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
33. Tomaszuk A, Simpson C, Williams G: Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res 1996; 46 : 53-8.
34. Baranowska B, Wasilewska-Dziubinska E, Radzikowska M, Plonowski A, Roguski K. Neuropeptide Y, galanin, and leptin release in obese woman and in women with anorexia nervosa. Metabolism 1997; 46: 1384-9.
35. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
36. White BD, Martin RJ. Evidence for a central mechanism of obesity in the Zucker rat: role of neuropeptide Y and leptin. Proc Soc Exp Biol Med 1997; 214: 222-32.
37. Bray G, Gallagher TF. Manifestation of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. Medicine 1975; 54: 301-30.
38. Herzog H, Selbie LA, Zee RY, Morris BJ, Shine J. Neuropeptide-Y Y1 receptor gene polymorphism: cross-sectional analyses in essential hypertension and obesity. Biochem Biophys Res Commun 1993; 196: 902-6.
39. Zimmet P, Hodge A, Nicolson N, et al. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 1996; 313: 965-9.
40. Bragagni G, Bianconcini G, Mazzali F, et al. Quarantatre casi di "empty sella syndrome" primitiva: contributo casistico. Ann Ital Med Int 1995; 10: 138-42.
41. Borgoni F, Giusti F, Venturini M, Furbatto A, Biagi P. La sindrome della sella vuota (empty sella syndrome) primitiva. Considerazioni a proposito di sei casi. Minerva Med 1993; 84: 233-8.